Tokyo - Delayed Quote JPY
Zeria Pharmaceutical Co., Ltd. (4559.T)
2,176.00
-153.00
(-6.57%)
At close: May 9 at 3:30:00 PM GMT+9
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
75,725,075
75,725,075
68,383,227
59,532,829
52,757,184
Cost of Revenue
20,223,758
20,223,758
18,894,627
17,384,577
15,796,484
Gross Profit
55,501,317
55,501,317
49,488,600
42,148,252
36,960,700
Operating Expense
45,879,669
45,879,669
40,473,626
35,782,192
33,484,983
Operating Income
9,621,648
9,621,648
9,014,974
6,366,060
3,475,717
Net Non Operating Interest Income Expense
-306,858
-306,858
-269,394
-298,223
-206,064
Pretax Income
9,508,394
9,508,394
7,272,698
5,721,764
3,956,545
Tax Provision
1,813,185
1,813,185
1,065,887
1,746,969
801,710
Net Income Common Stockholders
7,731,262
7,731,262
6,195,865
3,961,184
3,143,125
Diluted NI Available to Com Stockholders
7,731,262
7,731,262
6,195,865
3,961,184
3,143,125
Basic EPS
175.39
--
140.26
87.76
68.22
Diluted EPS
175.39
--
140.26
87.76
68.22
Basic Average Shares
44,080.06
--
44,173.35
45,139.01
46,071.76
Diluted Average Shares
44,080.06
--
44,173.35
45,139.01
46,071.76
Total Operating Income as Reported
9,621,647
9,621,647
9,014,973
6,366,058
3,475,716
Total Expenses
66,103,427
66,103,427
59,368,253
53,166,769
49,281,467
Net Income from Continuing & Discontinued Operation
7,731,262
7,731,262
6,195,865
3,961,184
3,143,125
Normalized Income
6,925,713.11
6,925,713.11
6,457,646.30
4,109,764.24
2,546,082.02
Interest Income
150,943
150,943
67,887
17,239
32,131
Interest Expense
457,801
457,801
337,281
315,462
238,195
Net Interest Income
-306,858
-306,858
-269,394
-298,223
-206,064
EBIT
9,966,195
9,966,195
7,609,979
6,037,226
4,194,740
EBITDA
17,521,645
17,521,645
13,758,249
11,437,771
8,630,799
Reconciled Cost of Revenue
20,223,758
20,223,758
18,894,627
17,384,577
15,796,484
Reconciled Depreciation
7,555,450
7,555,450
6,148,270
5,400,545
4,436,059
Net Income from Continuing Operation Net Minority Interest
7,731,262
7,731,262
6,195,865
3,961,184
3,143,125
Total Unusual Items Excluding Goodwill
995,365
995,365
-306,751
-213,883
747,893
Total Unusual Items
995,365
995,365
-306,751
-213,883
747,893
Normalized EBITDA
16,526,280
16,526,280
14,065,000
11,651,654
7,882,906
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
189,816.11
189,816.11
-44,969.70
-65,302.76
150,850.02
3/31/2021 - 1/1/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade